Protease Enzyme (Specialty Enzymes) – Contamination Risk (2013)
Class II: A situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Class II recall indicates potential for temporary health effects.
This AI-generated summary is provided for general informational purposes only and is derived from publicly available recall notices. It supplements but does not replace official agency classifications or safety instructions.
Check Your Product
According to the U.S. Food and Drug Administration (FDA)
Product
Protease: APEX 10-7082 CENTURY 7-152 EB 2-14511 EB 5-16901 EB 8-14861 EB 9-14191 EXCLZYME EXCLZYME EN GLOBAL 8-658 HFN 7-7113 META 10-185 MHNHEM 2-158 PEPZYME AG PROTEASE - 1000 PROTEASE 250,000 SEB PRO FP 500 SEB PRO FP 600 SYS 7-7742 UT 11-216 N VEGPANZYME 1213 VEGPANZYME PLUS
Brand
Specialty Enzymes & Biotechnologies
Lot Codes / Batch Numbers
Lot Numbers: 3071023 3071011 3071039 3061013 3051087 3071034 3031065 3031065 3051054, 3071020, 3061004 3071038 3061033 3061014 3051022, 3061041, 3071070, 3051092, 3071001 3051084, 3071060 3051038 3041051, 3071040 3061025 3071029 3051052 3071027 3071005
Products Sold
Lot Numbers: 3071023 3071011 3071039 3061013 3051087 3071034 3031065 3031065 3051054; 3071020; 3061004 3071038 3061033 3061014 3051022; 3061041; 3071070; 3051092; 3071001 3051084; 3071060 3051038 3041051; 3071040 3061025 3071029 3051052 3071027 3071005
Specialty Enzymes & Biotechnologies is recalling Protease: APEX 10-7082 CENTURY 7-152 EB 2-14511 EB 5-16901 EB 8-14861 EB 9-14191 EXCLZYME due to Specialty Enzymes and Biotechnologies is recalling cellulase/mannanase and fungal protease because they may contain low levels of chloramphenicol.. This is a Class I recall, indicating a high risk of serious health consequences. Based on FDA enforcement report.
Summary derived from FDA notice
Reason for Recall
As stated by FDA
Specialty Enzymes and Biotechnologies is recalling cellulase/mannanase and fungal protease because they may contain low levels of chloramphenicol.
Recommended Action
Per FDA guidance
Consumers should stop using the product and contact the recalling firm or return it to the place of purchase.
Verify this information on the official source
For complete details and official instructions, check the U.S. Food and Drug Administration (FDA) directly.
View official FDA recall noticePage updated: Jan 6, 2026